Status: Closed 5/6/03
Eligibility:

* First relapse of lymphoma following complete remission on conventional chemotherapy
* Measurable disease
* -B-cell lymphoma immunophenotype

Chemotherapy and Thrombospondin-I Therapy in dogs with lymphoma
Trial Support: Approximately 90% of the costs of care are provided by trial sponsor. Entry to trial can be undertaken at several participating veterinary centers across the United States, including all centers in the Animal Cancer Institute Network.